Snap up the last few tickets for Delving into Digital
We’re really excited to be hosting our third Delving into Digital summit next week. Don’t worry if you haven’t bought your ticket yet! We still have a few spaces remaining so make sure you take advantage of our 2 for 1 offer on all registrations for this event.

AMRC publishes new sector impact report
Last week we launched our new impact report that showcases outcomes from research funded by 44 AMRC member charities. The key findings are summarised in a two-page infographic and the full digital report takes an in-depth look at how charities make a difference in five different impact areas.

Spring has sprung
Last week, Chancellor Phillip Hammond delivered his annual Spring Statement which updates the Government’s financial commitments. Though light on research and innovation content, it was announced that a new international research and innovation strategy will be published in the coming months.

Health Secretary makes high profile speech on genomics
Yesterday Matt Hancock publicly outlined views on the future of genomics in the NHS. In a keynote speech and accompanying article, he emphasised the power of genomic technology to transform future healthcare.  

Obligatory Brexit update - we still don't know what's going on
The Prime Minister will ask for a short extension at today’s European Council meeting of EU leaders which she is likely going to get contingent on her deal being passed next week. If the deal is not passed, EU leaders are expected to hold a special Council meeting on 28 March and offer a longer extension to May.

How to make research funding transparent and fair
A new survey from NIHR builds on their previous work and aims to collate information about the different approaches to decision-making that health research funders are currently using, have used in the past or may consider using in the future, and their opinions of these approaches.

Pioneering pain research leads to landmark deal
King’s College London and Wellcome have announced an agreement with the pharmaceutical company MSD. The collaboration and licence deal, made possible by the pioneering work of Professor Peter McNaughton, could lead to a new class of pain medications.

New genetic data offers unprecedented resource for research
New genetic data from 50,000 people has today become available for health researchers, offering an unprecedented resource to enhance understanding of human biology and aid in therapeutic discovery.